Efficacy and Safety of FOLFIRINOX in Patients with Metastatic Pancreatic Cancer

CME test	Downloadable PDF	PowerPoint slides	CME Information and Faculty Disclosures
Read Dr Love's original email (from January 10, 2011)			Subscribe to Dr Love's email alerts

Slides from a presentation at ASH 2010 and transcribed comments from a recent interview with Rafael Fonseca, MD (12/22/10)

 

Conroy T et al. Randomized phase III trial comparing FOLFIRINOX (F: 5FU/leucovorin [LV], irinotecan [I], and oxaliplatin [O]) versus gemcitabine (G) as first-line treatment for metastatic pancreatic adenocarcinoma (MPA): Preplanned interim analysis results of the PRODIGE 4/ACCORD 11 trial. Proc ASCO 2010;Abstract 4010.

Go to previous Journal Club